Viewing Study NCT07187804

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2026-01-21 @ 12:29 AM
Study NCT ID: NCT07187804
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-23
First Post: 2025-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization
Sponsor: Kim's Eye Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age-related Macular Degeneration (ARMD) View
None Choroidal Neovascularization View
None Anti-vascular Endothelial Growth Factor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Age-related macular degeneration View
None Type 3 macular neovascularization View
None Retinal angiomatous proliferation View
None Faricimab View
None Treat and extend View